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Abstract
Many patients with depression have comorbidities associated with an impairment of sensor-
imotor gating, such as e.g. schizophrenia, Parkinson Disease, or Alzheimer disease. Anti-
depressants like clomipramine that modulate serotonergic or norepinephrinergic neurotrans-
mission have been shown to impact sensorimotor gating, it is therefore important to study
potential effects of clomipramine in order to rule out an exacerbation of sensorimotor gating
impairment. Prior studies in animals and humans have been inconclusive. Since serotonin and
norepinephrine levels are closely related to anxiety and stress levels and therefore to the social
status of an animal, we tested the hypothesis that acute and chronic effects of clomipramine on
sensorimotor gating are different in dominant versus subordinate rats, which might be
responsible for conﬂicting results in past animal studies. We used habituation and prepulse
inhibition (PPI) of the acoustic startle response as operational measures of sensorimotor gating.
After establishing the dominant animal in pair-housed male rats, we injected clomipramine for
two weeks and measured acute effects on baseline startle, habituation and PPI after the ﬁrst
injection and chronic effects at the end of the two weeks. Chronic treatment with
clomipramine signiﬁcantly increased habituation in subordinate rats, but had no effect on
habituation in dominant animals. Furthermore, PPI was slightly enhanced in subordinate rats
upon chronic treatment while no changes occurred in dominant animals. We conclude that the
social status of an animal, and therefore the basic anxiety/stress level determines whether or
not clomipramine has a beneﬁcial effect on sensorimotor gating and discuss possible underlying
mechanisms.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Clomipramine is widely prescribed to treat depression and
anxiety disorders (Dell'Osso et al., 2006). It is a competitive
antagonist that binds to monoamine transporters, so that
binding of the endogenous monoamine neurotransmitter is
inhibited (Apparsundaram et al., 2008). The resulting
increase of monoamines at synaptic sites may cause an
initial increase in anxiety levels (Browning et al., 2007;
Grillon et al., 2007). As chronic treatment persists, adaptive
changes seem to occur and therapeutic anxiolytic effects
can be seen (Bosker et al., 2010). While many monoami-
nergic re-uptake inhibitors have a limited selectivity and
affect serotonergic, norepinephrinergic and dopaminergic
systems, clomipramine has a high potency as a serotonin
and norepinephrine re-uptake inhibitor, but very limited
effects on the dopaminergic system. This is important, as
dopaminergic modulators are commonly known to impair
sensorimotor gating. Sensorimotor gating disruptions are
observed e.g. in schizophrenia, autism spectrum disorders,
and many neurodegenerative diseases, and they have been
shown to correlate with psychotic symptoms and/or cogni-
tive impairments. It is therefore speciﬁcally critical that
sensory gating deﬁciencies are not exacerbated when
clomipramine or other monoamine re-uptake inhibitors are
applied (Swerdlow et al., 2006b). Reports on the effects of
acute or chronic monoamine re-uptake inhibitors on sensor-
imotor gating in animals and humans have been conﬂicting
in the past (for details please see Section 4), probably due
to differences in the speciﬁcity of re-uptake inhibitors, and
their afﬁnity for different monoaminergic systems. Another
confounder might be the differences in basic anxiety or
stress level among patients and human volunteers or
between individual animals used in the studies. We here
address the latter by exploring the effect of clomipramine
in dominant versus subordinate rats, thereby taking differ-
ences in baseline anxiety and stress levels into account.
Social ranking in male rats and various other animals
correlates with anxiety and stress levels: rats demonstrating
lower anxiety related behaviour are considered to be more
active and aggressive in social behaviour (Henniger et al.,
2000) and they become dominant, as this behaviour is an
important part of survival and resource allocation in social
hierarchies (Davis et al., 2009). Interestingly, aggressive
behaviour and serotonin activity are closely related (Jansen
et al., 2011; Passamonti et al., 2012), as are social status
and serotonergic activity (for review see Chiao, 2010;
Whitaker et al., 2010; Morrison and Cooper, 2011;
Morrison et al., 2011; Issa et al., 2012). Increased stress
levels also induce norepinephrine release (Hajos-Korcsok
et al., 2003). We therefore hypothesise that the effect of
monoamine re-uptake inhibitors might be inﬂuenced by the
social status of an individual rat.
In order to address this hypothesis, we tested the acute
and chronic effects of clomipramine on the acoustic startle
response, habituation, and PPI in dominant versus subordi-
nate rats. Modulations of the acoustic startle response is the
most common method for studying sensorimotor gating in
humans and animals, whereas the baseline startle response
amplitude is an indicator of fear and anxiety levels.
2. Experimental procedures
2.1. Animals
A total of 54 Male Wistar Rats (Charles Rivers, Canada) of
approximately six weeks, weighing 250–320 g at the start of the
experiments were used in these studies. They were housed in cages
of two animals under continuous 12 h light–dark cycles, with water
ad libitum. The entire experiment was run three times. For the
second and third run, sexually experienced rats were used and they
were food restricted (20 g of standard rat chow per cage) for one
week prior to the startle experiments in order to increase aggres-
sive behaviour. All rats were weighed every two days to calculate
appropriate dosages of drugs. The experiments were done in
accordance with the ethical guidelines for the care and use of
laboratory animals for experiments by the Canadian Council for
Animal Research, and were approved by the local animal care
committee (University of Western Ontario).
2.2. Study design
The entire study was run three times each with 8 pairs of rats
(dominant and subordinate). An additional group of 6 rats that were
injected with saline through the entire study was run concurrently
with the second batch as a control group. For data analysis, we used
a within subject design, comparing initial startle data with data
after acute clomipramine treatment, chronic treatment, and after
2 weeks of recovery for each animal. All three experiments with
drug injections showed the same results, data for each group was
therefore merged and averaged across all three runs.
2.3. Determination of social status
Animals were housed in pairs and social behaviour was monitored
twice daily by two independent observer, once per light and per
dark cycle, for one week. Aggressive behaviour (ﬁghting, threaten-
ing) as well as resting positions in the cages were noted and used to
determine the dominant and subordinate animals (Henniger et al.,
2000). Fighting was monitored amongst pairs, as the winner
established his dominance through always gaining a superior posi-
tion on the subordinate rat. The latter often lied on its back or
submitted its head while the dominant one was stepping on top of
it. Resting/sleeping locations were also observed, as dominant rats
tended to rest inside a tube placed in the cage, and would ﬁght the
subordinate rat in order to establish its position. Alternatively, the
dominant rat would lie on top of the subordinate. After each
observation, rats within one cage were ranked dominant or
subordinate or as being inconclusive. After one week of observa-
tions, dominance rankings were tallied. Animals were considered
being dominant when at least 75% of observations were consistent
with dominant behaviours. Data of animals in a total of three cages
was omitted because no clear distinction could be determined
between the dominant and subordinate rat. In the last run of 16
rats, observation of social status was repeated immediately after
chronic treatment in order to see whether animals changed social
ranks through the treatment.
2.4. Injections
All rats were injected subcutaneously with saline (0.9% sodium
chloride) once every 12 h, for three days. Acoustic startle responses
were then measured for the control treatment. Testing was
repeated the next day after one subcutaneous injection of
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clomipramine (Sigma, Canada) to measure the acute effect of
clomipramine on startle response. A commonly used dose of
10 mg/kg body weight per injection was chosen. Other studies have
shown effects with doses as low as 1 mg/kg (e.g. Stuart et al.,
2013), or as high as 15 mg/kg per injection (e.g. Piras et al., 2014).
A small control group (n=6) received saline injections throughout
the experiment instead. Saline rats were not mixed with drug
treated animals in a cage in order to avoid that injections alter the
social status. Subcutaneous injections of clomipramine (or saline)
were continued every 12 h, for a total of 14 days and then the
startle response corresponding to chronic treatment was measured.
Upon completion of chronic treatment, rats were allowed to rest
for 14 days with no injections. They were then injected with saline
once, and startle response was recorded as a measure of recovery
from clomipramine. All measures of startle response occurred 15–
30 min after injection.
2.5. Acoustic startle response measurements
Four identical sound-attenuated chambers (100 80 60 cm3) were
used to measure acoustic startle responses (Med Associates, St Albans,
VT) using the Startle Reﬂex Software 5.95 (Med Associates, St. Albans,
VT). The differences between peak-to-peak voltage outputs of the
transducers were used to measure startle amplitudes. Animals were
ﬁrst subjected to a ten minute acclimation period with a 65 dB white
noise background, but without further stimulation. They were then
exposed to 30 startle pulse alone trials (20 ms, 110 dB white noise,
every 20 s) for habituation (Block I). Immediately following Block I, they
were subjected to 50 pseudo-randomized trials consisting of ﬁve
different stimulation types (Block II): startle pulse alone trials, and
four different prepulse-pulse trials with either 30 ms or 100 ms inter-
stimulus intervals (ISI) between prepulse and startle pulse and either
75 dB or 85 dB prepulse intensity (4 ms, white noise). Trials were
20 s apart (for experimental detail see Schmid et al., 2010; Valsamis
and Schmid, 2011). All animals were exposed to startle testing for ﬁve
times: after determination of social status, they were injected with
saline for 3 days. On the second day of injection they underwent a pre-
test in to get the animals used to the startle testing procedure. This
data was discarded. On the third day of saline injection, the second test
was performed for control measurements. On the subsequent day, they
were again tested after their ﬁrst injection of clomipramine (acute).
The fourth startle testing session was two weeks later, after their last
clomipramine injection (chronic). The last testing was done another two
weeks later, after the animals had recovered from the clomipramine
(recovery). Since all other startle testing sessions were preceded by an
injection, we injected saline before this last testing session.
2.6. Data and statistical analysis
Baseline startle was calculated by averaging the 10 startle alone trials in
Block II. Since habituation occurs most prominently within the ﬁrst 5–10
startle responses in rats, habituation score was determined by dividing
the mean of the last ﬁve startle responses by the mean of the ﬁrst two
startle responses in block I; it was expressed as a fraction of the initial
startle response (1.0) at the end of block I. PPI was calculated by
obtaining an average of the 10 trials corresponding to a particular
prepulse and ISI and dividing that value by the baseline startle response
(see above), according to the formula: 1-(startle response with
prepulse/baseline startle response). All PPI trials were veriﬁed for a
zero response to the prepulse before further analysis.
Repeated measure, one or two-way ANOVAs were used to
compare the effects of social status overall, as well as the effects
of treatments and interaction of treatments with social status.
Where Mauchly's test of sphericity was violated, either Huynh–Feldt
corrections (when ε40.75) or Greenhouse Geisser corrections
(when εo0.75) were used. Where signiﬁcant effects were found,
t-tests were run between the respective groups with the respective
Bonferroni correction for multiple comparisons. Statistics were run
in SPSS. In all experiments, n refers to the number of animals. A p
value ofo0.05 was used as the criterion for statistical signiﬁcance.
3. Results
3.1. Baseline startle
Baseline startle was measured after control injections of saline
(test 1, control), after one acute injection of clomipramine (test
2, acute), after 14 days of chronic exposure to clomipramine
(test 3, chronic), and two weeks after cessation of injections
(test 4, recovery). A repeated measures, two-way mixed design
ANOVA revealed no signiﬁcant difference of baseline startle
amplitudes between dominant and subordinate rats (F(1,45)=
0.13, po0.72), but a signiﬁcant effect of test number
(F(3,135)=26.99, po0.0001), and no interaction between test
number and social status (F(3,135)=0.89, p=0.97). In fact,
subordinate rats showed a consistent trend to exhibit higher
startle responses than dominant rats under control conditions,
but it failed to reach statistical signiﬁcance (t=1.75, p=0.092,
n=24 per group). In general, there was a continuous increase in
baseline startle across testing sessions in all rats (Figure 1 left).
In order to test whether this increase was due to the drug
treatment or to weight gain during repeated testing over time,
we ran a separate control group that received saline throughout
the entire time (Figure 1 right). A one-way repeated measure
ANOVA revealed a signiﬁcant increase in baseline startle
response amplitude over testing sessions in these saline injected
animals as well (F(3,12)=5.832, p=0.011), and a two-way
repeated measures ANOVA (mixed design) comparing saline
and clomipramine injected animals over the testing sessions
conﬁrmed a signiﬁcant change in baseline startle amplitude over
testing sessions (F(3,171)=21.7, po0.0001), but no effect of drug
(p=0.15) or interaction of drug with testing sessions (p=0.083).
In summary, while baseline startle amplitude increased through-
out the experiment in both the clomipramine and saline treated
animals, we did not detect a signiﬁcant inﬂuence of social status
or drug treatment on baseline startle.
3.2. Short-term habituation
Next, we tested short-term habituation in dominant versus
subordinate rats and how acute and chronic clomipramine
affected short-term habituation in rats with different social
status (Figure 2). A repeated measure, two-way ANOVA demon-
strated that there was no effect of treatment (F(3,135)=1.516,
p=0.22) or social status (F(1,41)=0.004, p=0.95), but a sig-
niﬁcant interaction between social status and drug treatment
(F(2.47,123)=3.73, p=0.02). A posthoc test revealed that sub-
ordinate animals had a signiﬁcantly higher habituation score
(i.e. habituated signiﬁcantly less) under control conditions than
their dominant cage mates (p=0.013). Dominant rats did not
display a signiﬁcant change in habituation scores due to acute
or chronic clomipramine injections, although there was a trend
towards less habituation after chronic treatment when com-
pared to control (p=0.078). In contrast, subordinate rats
showed a signiﬁcant increase in habituation (decrease of
scores) between control (test 1) and chronic treatment (test
3, p=0.016). There was also a signiﬁcant difference in
habituation between the dominant and subordinate rats after
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chronic clomipramine treatment (p=0.043). In summary, habi-
tuation increased in subordinate animals, whereas the stayed
the same or deteriorated in dominant animals. Interestingly,
this was accompanied with a shift in social status upon chronic
treatment: in 7 out of 8 cages observed for social ranking after
chronic treatment in the third run of the experiment the
animals either ﬂipped their rank order or no clear rank could be
determined anymore. No change in habituation upon repeated
testing was observed in the control animals that were injected
with saline throughout the experiment (F(3,12)=0.318, p=0.81).
In summary, chronic treatment with clomipramine signiﬁcantly
increased habituation (i.e. decreased habituation scores) in
subordinate rats but had no effect (with a trend to the opposite
effect) on habituation in dominant rats, demonstrating that
social status plays a role in clomipramine modulation of short-
term habituation.
3.3. Prepulse inhibition
The amount of PPI depends on the prepulse intensity and
the interval between the prepulse and the startle stimulus
(ISI). Lower prepulse intensities lead to lower PPI that is
often more vulnerable to pharmacological interventions. We
therefore used prepulses of 75 dB (4 ms), and 85 db (4 ms);
the latter prepulse induces very strong and robust PPI. PPI
disruptions have shown to be also dependent on the ISI, with
different neurotransmitters affecting PPI at distinct ISIs
(Bosch and Schmid, 2006; Vollenweider et al., 2007; Bosch
and Schmid, 2008; Yeomans et al., 2010). We therefore
tested PPI with two different ISIs of 30 ms and 100 ms. PPI
with different ISIs was analysed separately.
With the lower 75 db prepulse and an ISI of 30 a repeated
measure two way ANOVA revealed a signiﬁcant effect of
treatment (F(2.55,99.48)=3.98, po0.014), but not of social status
(F(1,39)=0.76, po0.78) or interaction of social status and
treatment (F(2.55,99.48)=1.60, po0.20). Pairwise comparison
showed that PPI was signiﬁcantly enhanced after chronic
injections in subordinate animals only when compared to initial
PPI under saline conditions (Figure 3, top). There was no
change in PPI in the saline injected animals (F(3,12)=0.223,
p=0.812). With the 75 dB prepulse and an ISI of 100 ms, no
signiﬁcant effects were found of treatment (F(3,117)=2.159,
p=0.097), social status (F(1,39)=0.399, p=0.531), or interaction
of treatment an social status (F(3,117)=0.70, p=0.554), see
ﬁgure 3bottom. There also was no change in PPI with a 75 dB
prepulse at ISIs of 100 ms in the saline injected group
(F(3,12)=1.180, p=0.358), indicating that the observed increase
in PPI at 75 dB/30 ms ISI was in fact due to the drug treatment
and not an improvement due to repeated testing.
At the stronger prepulse of 85 dB and an ISI of 30 ms, ANOVA
revealed a signiﬁcant effect of treatment (F(1.717,66.56)=11.40,
po0.0001), but no effect of social status (F(1,39)=0.021,
p=0.866) or interaction between social status and treatment
(F(1.71,66.56)= 1.44, p=0.245). Posthoc tests revealed a signiﬁ-
cant increase in PPI after chronic treatment in subordinate
animals. There was no change in PPI in the saline injected
group (F(3,12)=0.173, p=0.913, Figure 4, top). With the 100 ms
ISI, there was also a signiﬁcant effect of treatment
(F(3,117)=3.57, p=0.016), but no effect of social status
(F(1,39)=0.048, p=0.828), or interaction between social status
and treatment (F(3,117)=0.42, p=0.738) on the amount of PPI.
Again, posthoc tests revealed a signiﬁcant increase in PPI only
after chronic treatment in subordinate animals. There was no
change in PPI in the saline injected group (F(3,12)=1.218,
p=0.346), indicating that the observed increase in PPI was in
fact due to the drug treatment and not an improvement due to
repeated testing (Figure 4 bottom). In summary, PPI testing
revealed a signiﬁcant increase in PPI mostly after chronic
treatments in subordinate animals only.
In summary, clomipramine treatment did not seem to cause
any changes in baseline startle response amplitudes, but
chronic treatment signiﬁcantly improved habituation
Figure 1 Baseline startle responses. Left: baseline startle responses for dominant and subordinate animals (n=24 per group).
Baseline startle responses increased throughout the experiment. Although subordinate animals tended to display higher startle
responses initially, there was no statistical difference between dominant and subordinate animals. Right: a control group (n=6)
underwent exactly the same procedures but animals were injected with saline instead of clomipramine throughout the experiment.
Baseline startle also increased in this group of animals. There was no statistical difference in weight gain between clomipramine and
saline injected animals. Error bars show SEM.
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speciﬁcally in subordinate animals, while habituation in domi-
nant animals was mainly unaffected. Chronic clomipramine
treatment also mildly enhanced PPI in subordinate animals,
whereas it had no effect in dominant animals.
4. Discussion
Clomipramine is a widely used tricyclic antidepressant with
a very potent action on serotonin and norepinephrine re-
uptake and very limited effect on the dopaminergic
system. We here studied its effect on sensorimotor gating
and to what extent it depends on social status, without
trying distinguish between effects on the serotonergic
versus epinephrinergic systems. Both systems have pre-
viously shown to modulate startle responsiveness, habitua-
tion, and PPI, but results have been contradictory in the
past, especially in terms of serotonergic modulation (see
detailed discussion below). However, differences of basic
anxiety levels in humans or social status of laboratory
animals have not been monitored during experiments in
the past. The situation is further complicated by differ-
ences between species and strains, acute versus chronic
drug administration, and different testing protocol used. In
this study we therefore tested the effect of acute and
chronic clomipramine treatment on short-term habituation
and prepulse inhibition of startle in dominant versus
subordinate rats in order to account for differences in
anxiety levels before treatment. We also used different
prepulse levels and prepulse/pulse intervals. We found no
signiﬁcant differences in baseline startle or PPI between
dominant and subordinate rats under control conditions,
but signiﬁcantly reduced short-term habituation in sub-
ordinate animals. Clomipramine treatment had no effect
on baseline startle responses, but signiﬁcantly improved
habituation in subordinate rats upon chronic treatment.
PPI was slightly improved upon chronic treatment in
subordinate animals, especially at short ISIs.
Figure 2 Short-term habituation. (A) Left: average startle responses of 30 consecutive trials reveal short-term habituation in
dominant, but almost no habituation in subordinate rats under control conditions. Right: after chronic clomipramine treatment,
both groups show short term habituation to a similar extent. (B) Left: habituation scores were calculated for each animal averaging
the last ﬁve trials and divide them through the average of the ﬁrst two startle responses, since most habituation occurs within the
ﬁrst 5–10 startle responses in rats. Mean habituation scores are plotted as for dominant and subordinate rats after different drug
treatments. Dominant rats habituated to around 75–80% of their initial startle response under control conditions and after
treatments without any signiﬁcant changes. Subordinate animals habituated signiﬁcantly less than dominant animals under control
conditions (#). Habituation scores signiﬁcantly improved after chronic clomipramine treatment in subordinate rats when compared
to control measurements (*). After chronic clomipramine treatment the former subordinate rats showed signiﬁcantly more short-
term habituation than the former dominant rats (#). N=22 per group. Right: for direct comparison, habituation scores are plotted
for all animals treated with saline, showing that repeated testing or aging did not signiﬁcantly alter short-term habituation (n=6).
Error bars show SEM.
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4.1. Baseline startle
Fear-potentiated startle is a common paradigm for measur-
ing fear elicited by a conditioned stimulus presented in
combination with the startle eliciting stimulus (Davis et al.,
1993). Anxiety is considered to be a more general, uncondi-
tioned, form of discomfort and apprehension that is not
related to a certain stimulus and therefore generally
increases startle responses (for review see Davis, 1984;
Koch, 1999). We try to mimic differences in baseline anxiety
and stress levels by grouping male rats into dominant versus
subordinate animals. We had expected to see higher base-
line startle amplitudes in subordinate rats due to higher
anxiety levels. Indeed, we saw a trend towards higher
startle in subordinate animals; however, it failed to reach
statistical signiﬁcance. The baseline level of startle varies
immensely between individual animals in this outbred rat
strain, and this huge general variability could have masked a
subtle difference due to the social status. Also, baseline
startle response measurements are affected by weight – a
higher weight leads to a stronger startle signal on the
movement sensitive platform that was used to measure
the startle response. Subordinate rats may gain weight at a
slower pace than dominant rats which may counteract a
higher startle response, albeit we do not see a statistically
signiﬁcant weight difference between our animal groups
(data not shown). We also only tested a startle stimulus of
110 dB, which elicits maximum startle responses in most
animals. We cannot exclude the possibility that there are
differences in baseline startle between dominant and sub-
ordinate rats at lower stimulus intensities due to a lower
startle threshold in subordinate animals or a steeper input/
output function. Unfortunately, we could not measure
startle to different startle stimulus amplitudes since this
would have interfered with measurements of habituation.
Baseline startle increased in both groups throughout the
experiment. Previous studies have seen either no change in
baseline startle by serotonergic modulation in rats (Geyer and
Tapson, 1988; Martinez and Geyer, 1997) or an increase of
baseline startle in humans after acute modulations (Liechti
et al., 2001; Browning et al., 2007; Grillon et al., 2007).
Quednow et al. (2004) also found a trend for an increase in
baseline startle in humans after two weeks of SSRI administra-
tion, however, studies on chronic SSRI administration in rats
showed a reduced startle response (Bosker et al., 2010;
Homberg et al., 2011). Serotonergic raphe neurons have been
shown to directly project to startle neurons in the caudal
pontine reticular formation (PnC) (Steinbusch, 1981; Kolta
Figure 3 Prepulse inhibition with 75 dB prepulse intensity. Top: PPI in animals using a low prepulse intensity of 75 dB at 30 ms ISI.
The amount of inhibition (normalised to baseline startle of each animal) is plotted for different drug treatments. The prepulse
inhibited startle by around 50–60% and there was no difference between dominant and subordinate animals, however, subordinate
animals showed a small but signiﬁcant improvement in PPI upon chronic treatment when compared to initial PPI under saline
treatment (*, n=22 per group). Saline injected animals did not show any changes in PPI. Bottom: PPI in animals using a prepulse
intensity of 75 dB at 100 ms ISI was smaller with around 40% inhibition. There were no differences between dominant and
subordinate animals, nor did the drug treatment signiﬁcantly affect PPI, although a similar trend than observed above can be seen
(n=22 animals per group). Saline injected animals did also not show signiﬁcant changes in PPI (n=6). Error bars show SEM.
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et al., 1993). In the presence of serotonin, pH-sensitive
potassium channels (TASK-3) that are expressed in startle
mediating giant neurons in the PnC, are inactivated by 5-
HT2C receptor activation, which could theoretically cause an
increase in baseline startle response (Davis et al., 1986; Weber
et al., 2008). A similar serotonergic effect was also reported in
the startle pathway of the goldﬁsh (Curtin et al., 2013). Also,
acute norepinephrine increases arousal and thereby potentially
the startle reactivity. Indeed, epinephrine knock-out mice and
rats with lesions in the locus coeruleus show reduced startle
reactivity (Adams and Geyer, 1981) and fear potentiated startle
(Toth et al., 2013). However, it is difﬁcult to assess to what
extent the increase in baseline startle in our study was due to
clomipramine administration versus just a gain in weight.
Startle amplitudes also increased in saline injected control
animals, and our statistical analysis failed to detect any
signiﬁcant difference between saline and clomipramine
injected groups, indicating that weight gain was the major
factor driving the increase in startle amplitude.
4.2. Clomipramine effects on habituation
Although dominant and subordinate rats did not show statis-
tically signiﬁcant differences in initial startle response under
control conditions, this is the ﬁrst report showing that they
signiﬁcantly differ in the ability to habituate to repeated
startle stimuli. This is consistent with the theory that a high
anxiety level increases startle and leads to sensitization rather
than habituation upon repeated stimulation (Groves and
Thompson, 1970; Prescott, 1998). Acute administration of
the selective serotonin re-uptake inhibitor (SSRI) escitalopram
has shown a slowing effect on habituation in humans, which is
consistent with the initial increase in anxiety level during SSRI
intake (Jensen et al., 2007; Oranje et al., 2011), thus anxiety
levels might be one factor inﬂuencing the difference between
dominant and subordinate rats. Chronic administration of the
SSRI sertraline decreased habituation in patients with major
depression (Quednow et al., 2004). Accordingly, studies on
chronic SSRI administration in rats showed a reduced startle
response, and reduced habituation (Bosker et al., 2010;
Homberg et al., 2011). Norepinephrine has also been sug-
gested to oppose habituation by increasing sensitization
(Adams and Geyer, 1981). In contrast, we did not observe
any disruptions of habituation after clomipramine treatment,
but an improvement in habituation in subordinate rats after
chronic administration and no change (although a trend to less
habituation) in dominant animals. Interestingly, animals
tended to change the rank order through clomipramine
treatment as well, indicating that especially the subordinate
rats beneﬁt from the anxiolytic effect of clomipramine after
adaptive changes occurred.
Figure 4 Prepulse inhibition with 85 dB prepulse intensity: the amount of inhibition (normalised to baseline startle of each animal)
is plotted for different drug treatments. Under control conditions the startle response is reduced by around 65% (30 ms ISI, top) or
55% (100 ms ISI, bottom) of the baseline response. PPI slightly increased during treatment in subordinate animals, and signiﬁcantly
enhanced PPI upon chronic treatment (*, n= 22 animals per group). PPI did not change in saline treated animals throughout the
experiment (right). Error bars show SEM.
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Previous studies in humans have demonstrated that
patients with higher baseline startle amplitudes had a
stronger improvement of depressive symptoms when taking
SSRIs; thus it was suggested that the strength of the startle
at baseline could be used as a predictor for the efﬁcacy of
antidepressant therapy. Changes in baseline startle ampli-
tude were not signiﬁcantly correlated to improvement,
though (Quednow et al., 2004). Results of our study suggest
that the ability to habituate to startle stimuli, rather than
the baseline startle response amplitude itself, might be
predictive of the susceptibility to monoamine re-uptake
inhibitors.
4.3. Prepulse inhibition
The monoamine re-uptake inhibitor imipramine reduced PPI
(Hammer et al., 2007) which suggests a detrimental effect
of either serotonin or norepinephrine on PPI. Indeed, it has
been found consistently and repeatedly that stimulation of
α1 and β norepinephrine receptors results in PPI disruption,
and that PPI deﬁcits can be reversed by α1 and β receptor
antagonists (Bakshi and Geyer, 1998; Carasso et al., 1998;
Shilling et al., 2004; Alsene et al., 2006; Swerdlow et al.,
2006a; Alsene et al., 2010, 2011). Chronic administration of
the SSRI sertraline had no effect on PPI in patients with
major depression (Quednow et al., 2004). Accordingly,
studies on chronic SSRI in rats have shown no effect on
PPI (Bosker et al., 2010; Homberg et al., 2011).
MDMA has been reported to increase PPI without affecting
habituation in humans, whereas it was reported to disrupt
PPI and habituation in rodents. Effects in both models could
be reversed by serotonin re-uptake inhibitors (Vollenweider
et al., 1999; Liechti et al., 2001). In general, agonists for
the 5HT-1A receptors and antagonists to 5HT-2A seem to
enhance PPI or restore disrupted PPI (McFarland et al.,
2011; Price et al., 2012; Uchiumi et al., 2013) whereas 5HT-
1A antagonists and 5HT-2A agonists reduce PPI (Mansbach
and Geyer, 1989; Rigdon and Weatherspoon, 1992; Sipes and
Geyer, 1994; Fletcher et al., 2001; Prinssen et al., 2002;
Brosda et al., 2011; Wischhof et al., 2012). However, it was
also suggested that the attenuation in PPI through serotonin
depletion is also partially due a decrease in serotonin and
norepinephrine levels in the prefrontal cortex (Kusljic
et al., 2003). Accordingly, epinephrine deﬁcient mice also
show a higher degree of prepulse inhibition (Toth et al.,
2013). This is important in light of clomipramine displaying
its effects on both serotonergic and norepinephrinergic
activity (Dell'Osso et al., 2006). We found a signiﬁcant
enhancement of PPI with clomipramine that was more
pronounced at short ISI of 30 ms as compared to 100 ms
ISIs. In line with our ﬁndings, other studies have also found
serotonergic effects on PPI speciﬁcally with short ISIs
(Vollenweider et al., 2007).
4.4. Potential mechanisms of chronic
clomipramine
It was suggested that the effect of serotonin on PPI at short ISIs
is due to 5HT-2A receptor modulation in lower brain regions
that directly modulate startle, whereas at long ISIs a simulta-
neous and potentially counteracting stimulation of 5HT-1A on
cortical pyramidal cells come into play (Martin-Ruiz et al.,
2001; Martin-Ruiz and Ugedo, 2001; Vollenweider et al., 2007).
Thus, an adaptive down-regulation of 5HT-2A upon chronic
treatment could explain the habituation and PPI enhancement
speciﬁcally at short ISI. The difference in baseline serotonergic
signalling between dominant and subordinate animals might
explain the difference in sensitivity to this effect.
Recent studies suggest that the regulation of neurogen-
esis might also play a role in chronic effects of anti-
depressants. It has been shown that neurogenesis is
decreased by depression (Santarelli et al., 2003), as well
as by chronic stress (Lagace et al., 2010). Chronic social
defeat has been shown to induce stress and reduce neuro-
genesis by 50%, which could be reversed by chronic anti-
depressant treatment (Jiang et al., 2015), and the serotonin
and norepinephrine re-uptake inhibitor venlafaxine has
shown to increase neurogenesis in the hippocampus (Zhang
et al., 2015). It was suggested that neurogenesis speciﬁcally
in the ventral portion of the hippocampus (homologous to
the anterior hippocampus in humans) is relevant for anxiety
and mood regulation (for review see O'Leary and Cryan,
2014). Activity in the ventral hippocampus, however, has
also been shown to greatly inﬂuence sensorimotor gating,
most importantly PPI (Swerdlow et al., 1995; Zhang et al.,
2002; Adams et al., 2008; Rhein et al., 2013; Nguyen et al.,
2014). An increase in neurogenesis in the ventral hippo-
campus could therefore potentially be responsible for
changes in sensorimotor gating at longer ISIs in subordinate
rats upon chronic treatment with anti-depressants. Future
studies will have to address this hypothesis and further
explore the mechanisms underlying chronic effects of anti-
depressants on sensorimotor gating.
5. Conclusion
Our study suggests that the social status in rats has an
inﬂuence on the effect of chronic clomipramine on sensor-
imotor gating, especially on habituation, and that the
amount of habituation under control condition might be a
good predictor of the effect of clomipramine. Given that
the social status of a rat is indicative of anxiety and stress
levels, it would imply that clomipramine has different
effects in depressed patients than in human volunteers.
Our data further indicate that both habituation and/or
PPI are not disrupted, but can potentially be improved
through clomipramine. This is important when clomipra-
mine or similar drugs are applied to humans with schizo-
phrenia or other comorbidities associated with sensorimotor
deﬁcits, since it is critical not to exacerbate sensorimotor
gating deﬁciencies.
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